Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Central Glass Co., Ltd. ( (JP:4044) ) just unveiled an update.
Central Glass Co., Ltd. announced the sale of its consolidated subsidiary, Apollo Scientific Ltd., to Shanghai Titan Scientific Co., Ltd. due to ASL’s recent underperformance and the company’s strategic shift away from the reagent business. This decision aligns with Central Glass’s strategy to enhance corporate value by focusing on more profitable sectors, although it will result in an extraordinary loss in the upcoming fiscal year.
More about Central Glass Co., Ltd.
Central Glass Co., Ltd. operates in the fine chemicals industry, focusing on expanding its business through the reagent sector in Europe. The company has been involved in the production and sale of chemical products, with a market focus on optimizing its business portfolio by allocating resources to high-growth and profitable areas.
Average Trading Volume: 98,500
Technical Sentiment Signal: Buy
Current Market Cap: Yen76.2B
Find detailed analytics on 4044 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money